| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 6e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |